Madrigal Pharmaceuticals Inc (MDGL)

79.77 +0.42  +0.53% NASDAQ Oct 21, 10:20 USD

Madrigal Pharmaceuticals Profit Margin (Quarterly)

View 4,000+ financial data types
Browse...
View Full Chart

Profit Margin (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Profit Margin (Quarterly) Data

View and export this data going back to 2004. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2012 -10.24K%
Dec. 31, 2011 -313.8%
Sept. 30, 2011 -765.3%
June 30, 2011 -923.3%
March 31, 2011 -997.5%
Dec. 31, 2010 -218.6%
Sept. 30, 2010 -303.3%
June 30, 2010 -270.1%
March 31, 2010 -231.4%
Dec. 31, 2009 -150.4%
Sept. 30, 2009 90.58%
June 30, 2009 -182.7%
March 31, 2009 -521.0%
Dec. 31, 2008 -4.08K%
Sept. 30, 2008 -2.07K%
   
June 30, 2008 -1.70K%
March 31, 2008 -1.32K%
Dec. 31, 2007
Sept. 30, 2007
June 30, 2007
March 31, 2007
Dec. 31, 2006
Sept. 30, 2006
June 30, 2006
March 31, 2006
Dec. 31, 2005
Sept. 30, 2005
June 30, 2005
March 31, 2005
March 31, 2004 -5.06K%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Benchmarks

Akero Therapeutics Inc --
908 Devices Inc -89.69%
Twist Bioscience Corp -114.3%

News

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.